Identification of Biomarkers for Osteosarcoma Based on Integration Strategy
- PMID: 32173717
- PMCID: PMC7101204
- DOI: 10.12659/MSM.920803
Identification of Biomarkers for Osteosarcoma Based on Integration Strategy
Abstract
BACKGROUND Osteosarcoma (OS) is the most common primary malignant tumor of bone. The identification of novel biomarkers is necessary for the diagnosis and treatment of osteosarcoma. MATERIAL AND METHODS We obtained 11 paired fresh-frozen OS samples and normal controls from patients between September 2015 and February 2017. We used an integration strategy that analyzes next-generation sequencing data by bioinformatics methods based on the pathogenesis of osteosarcoma. RESULTS One susceptibility lncRNA and 7 susceptibility genes regulated by the lncRNA for osteosarcoma were effectively identified, and real-time PCR and clinical index ALP data were used to test their effectiveness. CONCLUSIONS The results showed that the expression levels of the 7 genes were highly consistent in the training and test sample sets, especially between the expression value of the gene ALPL and the plasma detection value of its encoded protein ALP. In particular, both the expression of gene ALPL and the plasma detection values of protein ALP encoded by gene ALPL showed a high degree of consistency among different data types. The identified lncRNA and genes effectively classified the samples proved so that they could be used as potential biomarkers of osteosarcoma. Our strategy may also be helpful for the identification of biomarkers for other diseases.
Figures
Similar articles
-
Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.Tumour Biol. 2016 Apr;37(4):4445-55. doi: 10.1007/s13277-015-4301-6. Epub 2015 Oct 25. Tumour Biol. 2016. PMID: 26499949
-
Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma.Oncology. 1996 Jul-Aug;53(4):275-80. doi: 10.1159/000227573. Oncology. 1996. PMID: 8692530
-
Novel classifiers with clinical laboratory parameters for early detection of osteosarcoma.J Clin Lab Anal. 2020 May;34(5):e23189. doi: 10.1002/jcla.23189. Epub 2020 Jan 8. J Clin Lab Anal. 2020. PMID: 31916312 Free PMC article.
-
Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets.Cell Physiol Biochem. 2017;42(4):1407-1419. doi: 10.1159/000479205. Epub 2017 Jul 17. Cell Physiol Biochem. 2017. PMID: 28715796 Review.
-
Long non-coding RNAs in osteosarcoma.Oncotarget. 2017 Mar 21;8(12):20462-20475. doi: 10.18632/oncotarget.14726. Oncotarget. 2017. PMID: 28103585 Free PMC article. Review.
Cited by
-
Integration of single-cell sequencing and bulk expression data reveals chemokine signaling pathway in proliferating cells is associated with the survival outcome of osteosarcoma.BMC Med Genomics. 2023 Aug 3;16(1):180. doi: 10.1186/s12920-023-01617-5. BMC Med Genomics. 2023. PMID: 37537613 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous